361 Capital’s CONMED CNMD Stock Holding History

361 Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,901	Closed	-$510K	–	319
2020 Q1	$510K	Sell	8,901 -2,111	-19%	-$195K	0.23%	233
2019 Q4	$1.23M	Sell	11,012 -19,200	-64%	-$2.05M	0.34%	156
2019 Q3	$2.9M	Sell	30,212 -689	-2%	-$64.7K	0.54%	33
2019 Q2	$2.64M	Sell	30,901 -10,996	-26%	-$904K	0.47%	88
2019 Q1	$3.48M	Buy	41,897 +3,882	+10%	+$282K	0.61%	5
2018 Q4	$2.44M	Buy	+38,015	New	+$2.6M	0.5%	51
2018 Q3	–	Sell	-23,173	Closed	-$1.7M	–	340
2018 Q2	$1.7M	Buy	+23,173	New	+$1.58M	0.38%	98

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

361 Capital's CNMD Position: Q2 2020 in Review

361 Capital sold out of CONMED (CNMD) in Q2 2020, closing a stake of 8,901 shares — an estimated $510K sold.

361 Capital first reported a position in CNMD in Q2 2018 and held it in 7 quarters. The position peaked at $3.48M in Q1 2019. 227 funds tracked by Wall St. Rank hold CNMD as of Q2 2020.

361 Capital reported no remaining CONMED position as of Q2 2020 after selling out during the quarter.
361 Capital sold 8,901 CONMED shares in Q2 2020, an estimated $510K.
361 Capital first reported a position in CONMED in Q2 2018 and held it in 7 quarters.
361 Capital's CONMED position peaked at $3.48M in Q1 2019.
227 funds tracked by Wall St. Rank held CONMED as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.